Spectrum Chemical will provide BASF precious-metal-containing powder catalysts in research quantities for early product development.
On Nov. 14, 2017, Spectrum Chemical, a US-based chemical manufacturer and distributor, announced that it entered an agreement with BASF, a producer and marketer of chemicals, to provide precious-metal-containing powder catalysts in research quantities to the North American market. According to Spectrum Chemical, this agreement will enable the speed up of commercialization and scale-up production by expanding access to smaller quantities of catalysts needed for early product development.
“We are excited to add these proven catalysts to our industry-leading chemistry portfolio,” said Randy Burg, president and CEO of Spectrum. “Our broad network of customers will receive access to products from the global leader in catalysts, but in the smaller quantities they need for early product development throughout North America.”
Under the agreement, Spectrum will offer 26 BASF catalysts containing precious metals including palladium, platinum, rhodium, and ruthenium, with carriers of carbon, alumina, and calcium carbonate.
Source: Spectrum Chemical
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.